Tissue Banking Market (2026 - 2033)

Tissue Banking Market Summary

The global tissue banking market size was valued at USD 27.5 billion in 2025 and is projected to grow from USD 29.3 billion in 2026 to USD 47.9 billion by 2033, at a CAGR of 7.3% from 2026 to 2033. Europe dominated the global market, accounting for the largest revenue share of 37.5% in 2025. The significant factors contributing to market growth include increasing demand for tissue transplantation procedures, growing adoption of regenerative medicine and cell-based therapies, and advancements in tissue preservation and biobanking technologies.

Case Study: Sheba Medical Center Establishes a GMP-Compliant Cardiovascular Tissue Bank

Background:

The Cardiovascular Tissue Bank at Sheba Medical Center (Israel) was established to improve the availability of high-quality cardiovascular tissue grafts for transplantation while ensuring compliance with Good Manufacturing Practice (GMP) standards. The tissue bank transitioned from conventional processing methods to a dedicated GMP-compliant cleanroom facility to enhance tissue quality, safety, and operational efficiency.

Challenge:

• Limited availability of high-quality cardiovascular tissue grafts for transplantation

• Need to comply with stringent GMP and tissue banking quality standards

• Requirement to maintain tissue viability and sterility throughout processing and cryopreservation

• Need for standardized tissue recovery, processing, and storage protocols to improve clinical outcomes

Solution:

Sheba Medical Center implemented a GMP-compliant cardiovascular tissue banking program with standardized donor screening, tissue recovery, processing, cryopreservation, microbiological testing, and quality assurance procedures.

Key capabilities include:

• GMP-grade cleanroom tissue processing

• Standardized donor screening and tissue recovery protocols

• Advanced cryopreservation and long-term tissue storage

• Comprehensive microbiological testing and quality control

• End-to-end tissue traceability and regulatory compliance

Results:

• Successfully processed 142 donor hearts between 2018 and 2025

• Produced 390 cardiovascular tissue grafts, with 338 approved for clinical transplantation

• Improved tissue quality, safety, and graft availability through standardized GMP processes

• Demonstrated a scalable hospital-based tissue banking model that can be replicated by other healthcare institutions

• Enhanced access to high-quality cardiovascular tissues for transplantation and clinical use

Market Dynamics

The rising demand for allografts in orthopedic, dental, cardiovascular, and wound care applications, growing investments in regenerative medicine and life sciences research, and continuous advancements in cryopreservation, automated storage, and tissue-processing technologies drive market growth. Companies and tissue banks are investing in advanced preservation systems, quality management practices, and storage infrastructure to ensure tissue safety, availability, and regulatory compliance. Increasing government support for tissue donation and transplantation programs, along with the expansion of clinical and research applications of human tissues, is further creating significant growth opportunities for the market.

Market Concentration & Characteristics

The chart below illustrates the relationship between market concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, regulatory impact, level of partnership and collaboration activities, degree of innovation, and regional expansion. For instance, the tissue banking market is slightly fragmented, with many products & service providers entering the market. The degree of innovation, the level of partnerships & collaboration activities, and the impact of regulations on the industry are high. However, the regional expansion observes moderate growth.

The degree of innovation in the tissue banking market is high, driven by advancements in tissue preservation technologies, processing infrastructure, and biobanking capabilities. Companies and healthcare institutions are investing in modern tissue banking facilities to improve tissue quality, availability, and clinical outcomes. For instance, in September 2025, the Maulana Azad Institute of Dental Sciences (MAIDS) launched India's first Central Tissue Bank, enabling the processing and supply of tissue and bone grafts while improving access to high-quality allografts for regenerative and reconstructive procedures.

The level of partnerships and collaborations in the tissue banking market is moderate, with organizations focusing on expanding tissue procurement networks, improving tissue accessibility, and supporting biomedical research. Strategic collaborations among tissue banks, organ procurement organizations, hospitals, and research institutions are strengthening tissue collection and distribution capabilities. For instance, in May 2026, Donor Network West and the University of California, San Francisco (UCSF) announced the VITAL Core program, a scalable collaboration that provides researchers with real-time access to viable donated organs and tissues unsuitable for transplantation. The program applies transplant-grade recovery and handling standards to research tissues, improving tissue quality and availability, and supporting biomedical research and scientific discovery.

Regulations have a significant impact on the tissue banking market as tissue banks and healthcare organizations must comply with stringent standards governing donor screening, tissue procurement, processing, preservation, storage, and distribution. Regulatory frameworks established by organizations such as the U.S. FDA, the European Union Tissue and Cells Directives (EUTCD), and national health authorities mandate strict quality management, traceability, and safety requirements. Compliance with these regulations is driving investments in advanced tissue-processing technologies, automated tracking systems, and quality-assurance programs to ensure tissue safety, product quality, and regulatory compliance.

Leading companies in the tissue banking market are expanding their regional presence through strategic partnerships, acquisitions, investments in tissue processing facilities, and collaborations with hospitals, transplant centers, and research institutes. These initiatives enable companies to strengthen tissue collection networks, increase processing and storage capacity, and improve access to high-quality donor tissues. Growing investments in regenerative medicine infrastructure and the expansion of tissue transplantation programs across emerging markets are further supporting regional market expansion.

Analyst Perspective

The tissue banking market is driven by increasing tissue transplantation procedures, growing adoption of regenerative medicine, and rising demand for high-quality human tissues for clinical and research applications. Tissue banks are expanding preservation capabilities and strengthening quality standards to support evolving healthcare and research needs. The market is also creating significant opportunities through advancements in tissue engineering and biobanking technologies, and through expanding investments in regenerative medicine, thereby supporting broader clinical and research applications of human tissues. Companies are investing in advanced cryopreservation technologies, automated biobanking systems, digital inventory management, and quality assurance capabilities to strengthen their market position. Strategic collaborations with hospitals, research institutes, and biotechnology companies, along with increased tissue donation initiatives and expanded applications in transplantation, tissue engineering, and drug discovery, are further driving market growth.

Product & Service Insights

The services segment accounted for the largest revenue share of 55.2% in 2025, driven by increasing demand for tissue collection, donor screening, processing, preservation, quality testing, storage, and distribution services. Healthcare organizations increasingly rely on specialized tissue banks and service providers to ensure regulatory compliance, high-quality tissue processing, and efficient supply for transplantation and research applications. The growing number of tissue donation and transplantation procedures, along with expanding regenerative medicine research, continues to drive demand for professional tissue banking services.

The products segment is anticipated to grow at the fastest CAGR over the forecast period from 2026 to 2033. This is due to the widespread adoption of tissue preservation media & consumables, as well as storage systems & equipment, across tissue banks and transplant centers. These products ensure tissue viability, sterility, and long-term preservation. Increasing investments in automated biobanking infrastructure and advanced cryogenic storage technologies are further driving product demand, while rising tissue transplantation procedures continue to support segment growth.

Tissue Type Insights

The musculoskeletal tissue segment held the largest revenue share of 23.4% in 2025, driven by the high volume of bone, tendon, ligament, cartilage, and soft tissue transplantation procedures performed globally. These tissues are widely used in orthopedic trauma, spinal fusion, sports medicine, dental reconstruction, and joint replacement surgeries. The increasing prevalence of musculoskeletal disorders, road accidents, and age-related degenerative diseases continues to drive demand for tissue grafts. Growing utilization of allografts in reconstructive surgeries further supports segment growth.

The placental & birth tissue segment is expected to grow significantly due to the increasing clinical use of amniotic membrane, umbilical cord tissue, and placental tissue in regenerative medicine and advanced wound care. These tissues possess anti-inflammatory and regenerative properties, making them valuable for orthopedic, ophthalmic, and chronic wound applications. Ongoing clinical research and commercialization of birth tissue-derived therapies are expanding their therapeutic applications. Rising awareness of birth tissue preservation is further contributing to market growth.

Storage Method Insights

The cryopreservation segment represented the largest market share of 49.5% in 2025 because it remains the gold standard for long-term preservation of human tissues while maintaining cellular viability and biological function. The method is widely used for musculoskeletal, cardiovascular, and placental tissues, as well as other transplantable grafts. Continuous technological advancements in cryogenic storage systems, temperature monitoring, and preservation media are improving storage reliability and tissue quality. Increasing investment in modern tissue-banking infrastructure continues to support the segment's dominance.

The room-temperature preservation segment is expected to grow at the fastest CAGR of 10.9% during the forecast period. This is due to the development of innovative preservation technologies that reduce reliance on cold-chain logistics. These solutions simplify storage, transportation, and handling while lowering operational costs for tissue banks and healthcare providers. Improved preservation media and stabilization technologies are expanding the range of tissues that can be stored under ambient conditions. Growing interest in decentralized healthcare delivery and resource-limited settings is further driving adoption.

Application Insights

The transplantation & tissue replacement segment accounted for the largest revenue share of 31.0% in 2025, driven by the increasing number of orthopedic, cardiovascular, ophthalmic, reconstructive, and dental surgeries requiring donor tissues. Rising incidences of trauma, chronic diseases, congenital abnormalities, and degenerative disorders continue to increase the demand for tissue grafts. Tissue banking plays a critical role in ensuring the safe processing, preservation, and timely availability of transplantable tissues. Improvements in transplantation success rates are also supporting sustained market demand.

The research & drug discovery segment is expected to experience a significant CAGR over the coming period. The increasing utilization of human tissues for biomedical research, disease modeling, biomarker discovery, and pharmaceutical development. High-quality banked tissues enable researchers to better understand disease mechanisms and evaluate novel therapeutic approaches. Pharmaceutical and biotechnology companies are expanding investments in tissue-based research to accelerate drug development and personalized medicine initiatives. Growing collaborations between tissue banks and research institutions are further supporting segment expansion.

End Use Insights

The hospitals & transplant centers segment held the largest market share of 28.6% in 2025, owing to the high volume of tissue procurement, preservation, storage, and transplantation procedures performed in these facilities. These institutions represent the primary end users of donor tissues for orthopedic, cardiovascular, ophthalmic, burn care, and reconstructive surgeries. The increasing establishment of specialized transplant programs and growing surgical volumes continue to strengthen demand for tissue banking products and services. Integration with advanced tissue processing and preservation technologies further supports segment growth.

The contract research organizations (CROs) segment is expected to grow at the fastest CAGR during the forecast period from 2026 to 2033. This is due to the increasing outsourcing of preclinical studies, clinical trials, tissue-based testing, and translational research by pharmaceutical and biotechnology companies. CROs are increasingly utilizing preserved human tissues to support drug discovery, toxicity testing, and biomarker validation. Growing demand for specialized research services and cost-effective development models is encouraging greater adoption of tissue banking solutions. The expansion of regenerative medicine and cell therapy research is further driving growth in the segment.

Regional Insights

Tissue banking market in Europe region held the largest revenue share of 37.5% in the global market in 2025, supported by well-established transplantation programs, increasing investments in regenerative medicine, and harmonized regulatory frameworks governing human tissues and cells. Growing demand for tissue grafts, expanding research activities, and collaborations between tissue banks and healthcare institutions continue to drive regional growth. The implementation of common regulatory standards for tissue safety and traceability is further strengthening market development.

UK Tissue Banking Market Trends

Tissue banking market in UK is expected to grow significantly over the forecast period, due to increasing organ and tissue donation initiatives, strong clinical research capabilities, and growing adoption of regenerative medicine. The presence of specialized tissue banks, the expansion of ophthalmic and musculoskeletal transplantation procedures, and continued investments in advanced preservation technologies are supporting market expansion.

Tissue banking market in Germany is driven by advanced healthcare infrastructure, rising numbers of transplantation procedures, and strong biomedical research capabilities. Growing investments in tissue engineering, regenerative medicine, and high-quality tissue-processing facilities, along with stringent quality and safety regulations, continue to support demand for tissue-banking products and services.

North America Tissue Banking Market Trends

Tissue banking market inNorth America is growing significantly share of the global tissue banking market in 2025. This is attributed to a well-established tissue donation and transplantation network, advanced healthcare infrastructure, high adoption of regenerative medicine, and leading tissue banks and biobanking technology providers. Strong regulatory oversight for tissue procurement, processing, and storage, coupled with increasing demand for musculoskeletal, cardiovascular, skin, and corneal tissue transplantation, continues to support market growth across the region.

The U.S. tissue banking market held the largest revenue share in 2025, driven by numerous tissue donation programs, advanced transplant centers, and significant investments in regenerative medicine and bio preservation technologies. Hospitals and research organizations are adopting advanced tissue preservation and storage technologies to improve graft quality and availability. For instance, in December 2025, LifeNet Health acquired Tissue Testing Technologies (T3) to strengthen its biopreservation capabilities and expand its use of advanced preservation technologies for clinical and research applications.

Asia Pacific Tissue Banking Market Trends

Tissue banking market in Asia Pacific is expected to have the fastest CAGR of 8.9% during the forecast period from 2026 to 2033. Market growth is driven by expanding healthcare infrastructure, increasing tissue transplantation procedures, rising investments in regenerative medicine, and growing government support for biobanking and life sciences research. Increasing awareness regarding tissue donation and the rapid expansion of biotechnology and pharmaceutical research activities are further accelerating regional market growth.

The China tissue banking market is one of the fastest-growing tissue banking markets in the Asia-Pacific region due to the rapid expansion of healthcare infrastructure, increasing transplantation activity, and substantial government investment in biotechnology and regenerative medicine. Growing research collaborations, expansion of biobanking facilities, and increasing adoption of advanced tissue preservation technologies are strengthening market growth across the country.

The Japan tissue banking market is witnessing steady growth in the tissue banking market owing to its strong focus on regenerative medicine, tissue engineering, and advanced cell therapies. The country continues to invest in innovative tissue-based therapies and clinical research.

Latin America Tissue Banking Market Trends

The Latin America tissue banking market is driven by improving healthcare infrastructure, increasing awareness of tissue donation, and gradual expansion of transplantation services. Rising investments in hospital modernization, expanding regenerative medicine research, and strengthening regulatory frameworks for tissue banking are contributing to market development. Brazil and Argentina continue to account for a significant share of the regional market due to their growing transplantation capabilities and research activities.

Middle East & Africa Tissue Banking Market Trends

The Middle East & Africa tissue banking market is experiencing significant growth, driven by increasing investments in healthcare infrastructure, expanding transplantation programs, and growing adoption of regenerative medicine across the region. Countries such as Saudi Arabia and the UAE are strengthening tissue banking capabilities through investments in advanced healthcare facilities, while South Africa continues to expand tissue donation and transplantation services. Increasing government support for biotechnology research, rising awareness of tissue donation, and the development of specialized tissue-processing and preservation facilities are further driving market growth across the region.

Key Tissue Banking Company Insights

Key players in the tissue banking market are adopting innovative strategies by expanding their tissue preservation and banking portfolios and investing in advanced cryopreservation technologies, automated storage systems, and digital inventory management solutions to improve tissue quality and operational efficiency. Strategic collaborations with hospitals, transplant centers, research institutes, and biotechnology companies.

Key Tissue Banking Companies

The following key companies have been profiled for this study on the tissue banking market.

• Thermo Fisher Scientific

• BioLife Solutions

• Custom Biogenic Systems

• Azenta Life Sciences

• MTF Biologics

• CorneaGen

• Hamilton Company

• BioCision

• LifeNet Health

• AlloSource

Competitive Benchmarking

Recent Developments

• In June 2026, LifeLink Tissue Bank and JRF Ortho announced a collaboration to expand access to sports tendon allografts for orthopedic and sports medicine procedures. The partnership combines LifeLink's tissue recovery, processing, and distribution capabilities with JRF Ortho's orthopedic allograft expertise to improve the availability of high-quality tendon grafts for ligament and tendon reconstruction.

“This collaboration represents a meaningful step forward in our mission to honor donors by maximizing the gift of tissue while improving patient lives. “By working alongside JRF Ortho, we’re able to extend our reach and provide customers with additional options that support clinical excellence.

- Mike Consilvio, General Manager of LifeLink Tissue Bank.

• In April 2026, AlloDirect launched the first direct-to-tissue-bank biologics marketplace for orthopedic surgeons, ambulatory surgery centers (ASCs), and hospitals. The platform connects healthcare providers directly with AATB-accredited tissue banks, enabling real-time inventory visibility, streamlined procurement, end-to-end traceability, and direct ordering of human allograft tissues.

Tissue Banking Market Report Scope

Global Tissue Banking Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global tissue banking market report by product & service, tissue type, storage method, application, end use, and region.

• Product & Service Outlook (Revenue, USD Million, 2021 - 2033)

  • Product

    • Media & Consumables

    • Storage Systems & Equipment

  • Service

• Tissue Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Musculoskeletal Tissue

  • Cardiovascular Tissue

  • Skin Tissue

  • Corneal Tissue

  • Placental & Birth Tissue

  • Other Tissues

• Storage Method Outlook (Revenue, USD Million, 2021 - 2033)

  • Cryopreservation

  • Refrigerated Storage

  • Room Temperature Preservation

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Transplantation & Tissue Replacement

  • Regenerative Medicine & Tissue Engineering

  • Research & Drug Discovery

  • Other Applications

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & Transplant Centers

  • Academic & Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Contract Research Organizations (CROs)

  • Others

• Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The tissue banking market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each tissue banking segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations